QA: Endocyte INC in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001235007_2014_Endocyte_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001235007, Endocyte INC

  xvar xval
0 AssetsCurrent 133,331,530
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,839,426
3 remainder_Assets 25,686,620
4 LiabilitiesCurrent 73,663,457
5 LiabilitiesNoncurrent 33,458
6 remainder_Liabilities 931,940
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,313,731
9 ResearchAndDevelopmentExpense 57,898,971
10 remainder_Expenses 2,458
11 remainder_Revenues 64,870,919
12 remainder_NetIncome 311,803
13 remainder_ComprehensiveNetIncome -16,058
  yvar yval
0 Assets 162,857,576
1 Liabilities 74,628,855
2 Expenses 83,215,160
3 Revenues 64,870,919
4 StockholdersEquity 88,228,721
5 NetIncome -18,032,438
6 ComprehensiveNetIncome -18,040,467
7 BaseVar 192,950,186
8 EconomicCapitalRatiobeforeLimitedLiability 1.47
9 EconomicCapitalRatio 2.66

Edgar->Model Mapping

Feature Distribution

Change over Time